|
|
|
(State or other jurisdiction of incorporation or organization)
|
(I.R.S. Employer Identification No.)
|
|
|
|
(Address of principal executive offices)
|
(Zip Code)
|
Title of each class
|
Trading Symbol
|
Name of each exchange on which registered
|
||
|
|
|
Large accelerated filer ☐
|
Accelerated filer ☐
|
|
|
Smaller reporting company
|
|
Emerging growth company
|
Class |
Outstanding at April 28, 2022
|
||
Class A Common Stock, .001 par value
|
|
||
Class B Common Stock, .001 par value
|
|
PART I.
|
FINANCIAL INFORMATION
|
Page
|
Item 1.
|
Unaudited Condensed Consolidated Financial Statements:
|
|
3
|
||
4
|
||
5
|
||
6
|
||
7
|
||
9
|
||
10
|
||
11
|
||
12 | ||
14
|
||
16
|
||
17
|
||
17
|
||
18
|
||
19
|
||
19
|
||
Item 2.
|
20
|
|
Item 3.
|
26
|
|
Item 4.
|
26
|
|
PART II.
|
OTHER INFORMATION *
|
|
Item 1.
|
28
|
|
Item 2.
|
28
|
|
Item 6.
|
29
|
|
31
|
* |
Items other than those listed above have been omitted because they are not applicable.
|
March 31,
2022
|
December 31,
2021
|
|||||||
ASSETS
|
||||||||
Cash and cash equivalents (includes U.S. Treasury Bills with maturities of less than 3 months)
|
$
|
|
$
|
|
||||
Investments in U.S. Treasury Bills with greater than 3 month maturities
|
|
|
||||||
Investments in equity securities (Including GBL stock with a value of $
|
|
|
||||||
Investments in affiliated registered investment companies
|
|
|
||||||
Investments in partnerships
|
|
|
||||||
Receivable from brokers
|
|
|
||||||
Investment advisory fees receivable
|
|
|
||||||
Receivable and investment in note receivable from affiliates
|
|
|
||||||
Goodwill
|
|
|
||||||
Other assets
|
|
|
||||||
Investments in marketable securities held in trust
|
|
|
||||||
Total assets
|
$
|
|
$
|
|
||||
LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS AND EQUITY
|
||||||||
Payable to brokers
|
$
|
|
$
|
|
||||
Income taxes payable, including deferred tax liabilities, net
|
|
|
||||||
Compensation payable
|
|
|
||||||
Securities sold, not yet purchased
|
|
|
||||||
Accrued expenses and other liabilities
|
|
|
||||||
Deferred underwriting fee payable
|
|
|
||||||
PMV warrant liability |
||||||||
Total liabilities
|
|
|
||||||
Redeemable noncontrolling interests
|
|
|
||||||
Commitments and contingencies (Note J)
|
||||||||
Equity:
|
||||||||
Preferred stock, $
|
||||||||
Class A Common Stock, $
|
|
|
||||||
Class B Common Stock, $
|
|
|
||||||
Additional paid-in capital
|
|
|
||||||
Retained earnings
|
|
|
||||||
Treasury stock, at cost (
|
(
|
)
|
(
|
)
|
||||
Total Associated Capital Group, Inc. equity
|
|
|
||||||
Noncontrolling interests
|
(
|
)
|
(
|
)
|
||||
Total equity
|
|
|
||||||
Total liabilities and equity
|
$
|
|
$
|
|
Three Months Ended
March 31,
|
||||||||
2022
|
2021
|
|||||||
Revenues
|
||||||||
Investment advisory and incentive fees
|
$
|
|
$
|
|
||||
Other
|
|
|
||||||
Total revenues
|
|
|
||||||
Expenses
|
||||||||
Compensation
|
|
|
||||||
Management fee
|
|
|
||||||
Other operating expenses
|
|
|
||||||
Total expenses
|
|
|
||||||
Operating loss
|
(
|
)
|
(
|
)
|
||||
Other income (expense)
|
||||||||
Net gain/(loss) from investments
|
(
|
)
|
|
|||||
Interest and dividend income
|
|
|
||||||
Interest expense
|
(
|
)
|
(
|
)
|
||||
Shareholder-designated contribution
|
(
|
)
|
(
|
)
|
||||
Total other income (expense), net
|
(
|
)
|
|
|||||
Income/(loss) before income taxes
|
(
|
)
|
|
|||||
Income tax expense/(benefit)
|
(
|
)
|
|
|||||
Income/(loss) before noncontrolling interests
|
(
|
)
|
|
|||||
Income/(loss) attributable to noncontrolling interests
|
|
|
||||||
Net income/(loss) attributable to Associated Capital Group, Inc.’s shareholders
|
$
|
(
|
)
|
$
|
|
|||
Net income/(loss) per share attributable to Associated Capital Group, Inc.’s shareholders:
|
||||||||
Basic
|
$
|
(
|
)
|
$
|
|
|||
Diluted
|
$
|
(
|
)
|
$
|
|
|||
Weighted average shares outstanding:
|
||||||||
Basic
|
|
|
||||||
Diluted
|
|
|
||||||
Actual shares outstanding:
|
|
|
Three Months Ended
March 31,
|
||||||||
2022
|
2021
|
|||||||
Net income/(loss) before noncontrolling interests
|
$
|
(
|
)
|
$
|
|
|||
Less: Comprehensive income/(loss) attributable to noncontrolling interests
|
|
|
||||||
Comprehensive income/(loss) attributable to Associated Capital Group, Inc.
|
$
|
(
|
)
|
$
|
|
Associated Capital Group, Inc. Shareholders
|
||||||||||||||||||||||||||||||||
Common
Stock
|
Retained
Earnings
|
Additional
Paid-in
Capital
|
Treasury
Stock
|
Total
|
Noncontrolling
Interests
|
Total
Equity
|
Redeemable
Noncontrolling
Interests
|
|||||||||||||||||||||||||
Balance at December 31, 2021
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
|
||||||||||||||
Redemptions of noncontrolling interests |
|
|
|
|
|
|
(
|
)
|
||||||||||||||||||||||||
Net income/(loss)
|
(
|
)
|
|
|
(
|
)
|
|
(
|
)
|
|
||||||||||||||||||||||
Purchase of treasury stock
|
|
|
|
(
|
)
|
(
|
)
|
|
(
|
)
|
|
|||||||||||||||||||||
Accretion of redeemable noncontrolling interests |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||
Other changes to redeemable noncontrolling interests |
( |
) | ||||||||||||||||||||||||||||||
Balance at March 31, 2022
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
|
Associated Capital Group, Inc. Shareholders
|
||||||||||||||||||||||||||||||||
|
Common
Stock
|
Retained
Earnings
|
Additional
Paid-in
Capital
|
Treasury
Stock
|
Total
|
Noncontrolling
Interests
|
Total
Equity
|
Redeemable
Noncontrolling
Interests
|
||||||||||||||||||||||||
Balance at December 31, 2020
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
|
$
|
|
$
|
|
|||||||||||||||
Contributions from redeemable noncontrolling interests |
||||||||||||||||||||||||||||||||
Redemptions of noncontrolling interests
|
|
|
|
|
|
|
(
|
)
|
||||||||||||||||||||||||
Net income
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
Purchase of treasury stock
|
|
|
|
(
|
)
|
(
|
)
|
|
(
|
)
|
|
|||||||||||||||||||||
Balance at March 31, 2021
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
|
$
|
|
$
|
|
Three Months Ended
March 31,
|
||||||||
2022
|
2021
|
|||||||
Operating activities
|
||||||||
Net income/(loss)
|
$
|
(
|
)
|
$
|
|
|||
Adjustments to reconcile net income/(loss) to net cash provided by/(used in) operating activities:
|
||||||||
Equity in net (gains) losses from partnerships
|
|
(
|
)
|
|||||
Depreciation and amortization
|
|
|
||||||
Deferred income taxes
|
(
|
)
|
|
|||||
Donated securities
|
|
|
||||||
Unrealized (gains)/losses on securities
|
|
(
|
)
|
|||||
Realized gains on sales of securities
|
(
|
)
|
(
|
)
|
||||
(Increase)/decrease in assets:
|
||||||||
Investments in trading securities
|
|
|
||||||
Investments in partnerships:
|
||||||||
Contributions to partnerships
|
(
|
)
|
(
|
)
|
||||
Distributions from partnerships
|
|
|
||||||
Receivable from affiliates
|
|
|
||||||
Receivable from brokers
|
(
|
)
|
(
|
)
|
||||
Investment advisory fees receivable
|
|
|
||||||
Income taxes receivable
|
|
(
|
)
|
|||||
Other assets
|
(
|
)
|
||||||
Increase/(decrease) in liabilities:
|
||||||||
Payable to affiliates
|
|
(
|
)
|
|||||
Payable to brokers
|
|
|
||||||
Income taxes payable
|
|
|
||||||
Compensation payable
|
(
|
)
|
(
|
)
|
||||
Accrued expenses and other liabilities
|
(
|
)
|
(
|
)
|
||||
Total adjustments
|
|
|
||||||
Net cash provided by operating activities
|
|
|
||||||
Investing activities
|
||||||||
Maturities of marketable securities held in trust |
||||||||
Purchases of marketable securities held in trust |
( |
) | ||||||
Purchases of securities
|
(
|
)
|
(
|
)
|
||||
Proceeds from sales of securities
|
|
|
||||||
Return of capital on securities
|
|
|
||||||
Net cash provided by/(used in) investing activities
|
$
|
(
|
)
|
$
|
|
Three Months Ended
March 31,
|
||||||||
2022
|
2021
|
|||||||
Financing activities
|
||||||||
Purchase of treasury stock
|
(
|
)
|
(
|
)
|
||||
Contributions from redeemable noncontrolling interests
|
|
|
||||||
Redemptions of redeemable noncontrolling interests | ( |
) | ||||||
Net cash provided by (used in) financing activities
|
(
|
)
|
(
|
)
|
||||
Net increase in cash, cash equivalents and restricted cash
|
|
|
||||||
Cash, cash equivalents and restricted cash at beginning of period
|
|
|
||||||
Cash, cash equivalents and restricted cash at end of period
|
$
|
|
$
|
|
||||
Supplemental disclosures of cash flow information:
|
||||||||
Cash paid for interest
|
$
|
|
$
|
|
||||
Cash paid/(received) for taxes
|
$
|
|
$
|
|
Cash and cash equivalents
|
|
|
||||||
Restricted cash included in receivable from brokers
|
|
|
||||||
Cash, cash equivalents and restricted cash at end of period
|
$
|
|
$
|
|
Three Months Ended March 31,
|
||||||||
2022
|
2021
|
|||||||
Investment advisory and incentive fees
|
||||||||
Asset-based advisory fees
|
$
|
|
$
|
|
||||
Performance-based advisory fees
|
|
|
||||||
Sub-advisory fees
|
|
|
||||||
Sub-total |
|
|
||||||
|
||||||||
Other
|
||||||||
Miscellaneous
|
|
|
||||||
|
||||||||
Total
|
$
|
|
$
|
|
March 31, 2022
|
December 31, 2021
|
|||||||||||||||
Cost
|
Fair Value
|
Cost
|
Fair Value
|
|||||||||||||
Debt - Trading Securities:
|
||||||||||||||||
U.S. Treasury Bills
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
Equity Securities:
|
||||||||||||||||
Common stocks
|
|
|
|
|
||||||||||||
Mutual funds
|
|
|
|
|
||||||||||||
Other investments
|
|
|
|
|
||||||||||||
Total investments in equity securities
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
Investments in marketable securities held in trust(1) | $ | $ | $ | $ |
March 31, 2022
|
||||||||||||||||
Amortized Cost
|
Gross Unrealized
Holding Gains
|
Gross Unrealized
Holding Losses
|
Estimated
Fair Value
|
|||||||||||||
Held to maturity:
|
||||||||||||||||
Investment in note receivable from affiliate(2)
|
$ | $ | $ | $ |
December 31, 2023
|
||||||||||||||||
Amortized Cost
|
Gross Unrealized
Holding Gains
|
Gross Unrealized
Holding Losses
|
Estimated
Fair Value
|
|||||||||||||
Held to maturity:
|
||||||||||||||||
Investment in note receivable from affiliate(2)
|
$ | $ | $ | $ |
March 31, 2022
|
December 31, 2021
|
|||||||||||||||
Cost
|
Fair Value
|
Cost
|
Fair Value
|
|||||||||||||
Equity securities:
|
||||||||||||||||
Common stocks
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
Other investments
|
|
|
|
|
||||||||||||
Total securities sold, not yet purchased
|
$
|
|
$
|
|
$
|
|
$
|
|
March 31, 2022
|
December 31, 2021
|
|||||||||||||||
Cost
|
Fair Value
|
Cost
|
Fair Value
|
|||||||||||||
Equity securities:
|
||||||||||||||||
Closed-end funds
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
Mutual funds
|
|
|
|
|
||||||||||||
|
||||||||||||||||
Total investments in affiliated registered investment
companies
|
$
|
|
$
|
|
$
|
|
$
|
|
March 31, 2022
|
||||||||||||
Prior to
Consolidation
|
Consolidated
Entities
|
As Reported
|
||||||||||
Total assets
|
$
|
|
$
|
|
$
|
|
||||||
Liabilities and equity
|
||||||||||||
Total liabilities
|
|
|
|
|||||||||
Redeemable noncontrolling interests
|
|
|
|
|||||||||
Total equity(1)
|
|
(
|
)
|
|
||||||||
Total liabilities and equity
|
$
|
|
$
|
|
$
|
|
December 31, 2021
|
||||||||||||
Prior to
Consolidation
|
Consolidated
Entities
|
As Reported
|
||||||||||
Total assets
|
$
|
|
$
|
|
$
|
|
||||||
Liabilities and equity
|
||||||||||||
Total liabilities
|
|
|
|
|||||||||
Redeemable noncontrolling interests
|
|
|
|
|||||||||
Total equity(1)
|
|
(
|
)
|
|
||||||||
Total liabilities and equity
|
$
|
|
$
|
|
$
|
|
Three Months Ended March 31, 2022
|
||||||||||||
Prior to
Consolidation
|
Consolidated
Entities
|
As Reported
|
||||||||||
Total revenues
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||
Operating loss
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
Total other income/(expense), net
|
(
|
)
|
|
(
|
)
|
|||||||
Income/(loss) before noncontrolling interests, net of taxes
|
(
|
)
|
|
(
|
)
|
|||||||
Income attributable to noncontrolling interests
|
|
|
|
|||||||||
Net income/(loss)
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
Three Months Ended March 31, 2021
|
||||||||||||
Prior to
Consolidation
|
Consolidated
Entities
|
As Reported
|
||||||||||
Total revenues
|
$
|
|
$
|
|
$
|
|
||||||
Operating loss
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
Total other income, net
|
|
|
|
|||||||||
Income before noncontrolling interests, net of taxes
|
|
|
|
|||||||||
Income attributable to noncontrolling interests
|
|
|
|
|||||||||
Net income/(loss)
|
$
|
|
$
|
(
|
)
|
$
|
|
March 31,
2022
|
December 31,
2021
|
|||||||
Cash and cash equivalents
|
$
|
|
$
|
|
||||
Investments in securities
|
|
|
||||||
Receivable from brokers
|
|
|
||||||
Investments in partnerships and affiliates
|
|
|
||||||
Investments in marketable securities held in trust |
||||||||
Other assets
|
|
|
||||||
Accrued expenses and other liabilities(1)
|
(
|
)
|
(
|
)
|
||||
PMV warrant liability |
( |
) | ( |
) | ||||
Redeemable noncontrolling interests
|
(
|
)
|
(
|
)
|
||||
Nonredeemable noncontrolling interests
|
|
|
||||||
AC Group’s net interests in consolidated VIEs
|
$
|
|
$
|
|
•
|
Level 1 - Unadjusted quoted prices for identical instruments in active markets.
|
•
|
Level 2 - Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and
model-derived valuations in which all significant inputs and significant value drivers are observable.
|
•
|
Level 3 - Valuations derived from valuation techniques in which significant inputs or significant value drivers are unobservable.
|
March 31, 2022
|
||||||||||||||||
Assets
|
Quoted Prices in
Active Markets
for Identical
Assets (Level 1)
|
Significant
Other
Observable
Inputs (Level 2)
|
Significant
Unobservable
Inputs (Level 3)
|
Total
|
||||||||||||
Cash equivalents
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
Investments in securities (including GBL stock):
|
||||||||||||||||
Trading - U.S. Treasury Bills
|
|
|
|
|
||||||||||||
Common stocks
|
|
|
|
|
||||||||||||
Mutual funds
|
|
|
|
|
||||||||||||
Other
|
|
|
|
|
||||||||||||
Total investments in securities
|
|
|
|
|
||||||||||||
Investments in affiliated registered investment companies:
|
||||||||||||||||
Closed-end funds
|
|
|
|
|
||||||||||||
Mutual funds
|
|
|
|
|
||||||||||||
Total investments in affiliated registered investment companies
|
|
|
|
|
||||||||||||
Total investments held at fair value
|
|
|
|
|
||||||||||||
Total assets at fair value
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
Liabilities
|
||||||||||||||||
Common stocks
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
Other
|
|
|
|
|
||||||||||||
Securities sold, not yet purchased
|
|
|
|
|
|
|
|
|
||||||||
PMV warrant liability |
||||||||||||||||
Total liabilities at fair value |
$ | $ | $ | $ |
December 31, 2021
|
||||||||||||||||
Assets
|
Quoted Prices in
Active Markets
for Identical
Assets (Level 1)
|
Significant
Other
Observable
Inputs (Level 2)
|
Significant
Unobservable
Inputs (Level 3)
|
Total
|
||||||||||||
Cash equivalents
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
Investments in securities (including GBL stock):
|
||||||||||||||||
Trading - U.S. Treasury Bills
|
|
|
|
|
||||||||||||
Common stocks
|
|
|
|
|
||||||||||||
Mutual funds
|
|
|
|
|
||||||||||||
Other
|
|
|
|
|
||||||||||||
Total investments in securities
|
|
|
|
|
||||||||||||
Investments in affiliated registered investment
companies:
|
||||||||||||||||
Closed-end funds
|
|
|
|
|
||||||||||||
Mutual funds
|
|
|
|
|
||||||||||||
Total investments in affiliated registered investment
companies
|
|
|
|
|
||||||||||||
Total investments held at fair value
|
|
|
|
|
||||||||||||
Total assets at fair value
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
Liabilities
|
||||||||||||||||
Common stocks
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
Other
|
|
|
|
|
||||||||||||
Securities sold, not yet purchased
|
|
|
|
|
||||||||||||
PMV warrant liability |
||||||||||||||||
Total liabilities at fair value |
$ | $ | $ | $ |
Three Months Ended March 31,
|
||||||||
2022
|
2021
|
|||||||
Assets: |
||||||||
Beginning balance
|
$
|
|
$
|
|
||||
Total gains/(losses)
|
|
(
|
)
|
|||||
Purchases
|
|
|
||||||
Sales
|
(
|
)
|
|
|||||
Transfers
|
|
(
|
)
|
|||||
Ending balance
|
$
|
|
$
|
|
||||
Changes in net unrealized gain/(loss) included in Net gain/(loss) from investments
related to level 3 assets still held as of the reporting date
|
$
|
|
$
|
(
|
)
|
|
As of March 31, 2022
|
As of December 31, 2021
|
||||||||||||||||||||||
Assets
|
Level Within
Fair Value
Hierarchy
|
Fair Value
|
Amortized Cost
|
Level Within
Fair Value
Hierarchy
|
Fair Value
|
Amortized Cost
|
||||||||||||||||||
|
||||||||||||||||||||||||
Investment in note receivable from affiliate(1)
|
2
|
$
|
|
$
|
|
2
|
$
|
|
$
|
|
||||||||||||||
Total assets
|
$
|
|
$
|
|
|
$
|
|
$
|
|
Three Months Ended
March 31,
|
||||||||
(In thousands, except for per share amounts)
|
2022
|
2021
|
||||||
Income/(loss) before
noncontrolling interests
|
$
|
(
|
)
|
$
|
|
|||
Less: Income/(loss) attributable to noncontrolling interests
|
|
|
||||||
Net income/(loss) attributable to Associated Capital Group,
Inc.’s shareholders
|
$ |
(
|
)
|
$ |
|
|||
Weighted average number of shares of Common Stock outstanding -
basic
|
|
|
||||||
Weighted average number of shares of Common Stock outstanding -
diluted
|
|
|
||||||
Basic and Diluted EPS
|
$
|
(
|
)
|
$
|
|
|
Three Months Ended
March 31,
|
|||||||
|
2022
|
2021
|
||||||
Stock-based compensation expense
|
$ | $ | ||||||
Remaining expense to be recognized if all vesting conditions are met(1)
|
$
|
|
$
|
|
||||
Weighted average remaining contractual term (in years)
|
|
|
RSA’s |
Weighted
Average Grant
Date Fair Value
|
|||||||
Balance at December 31, 2021
|
|
$
|
|
|||||
Granted
|
|
|
||||||
Forfeited
|
(
|
)
|
|
|||||
Vested
|
|
|
||||||
Balance at March 31, 2022
|
|
$
|
|
Number of shares purchased
|
Average price per share
|
|||||||
Remaining repurchase authorization December 31, 2021
|
|
|||||||
Share repurchase plan(1)
|
(
|
)
|
$
|
|
||||
Remaining repurchase authorization March 31, 2022
|
|
Remaining repurchase authorization December 31, 2020
|
|
|||||||
Share repurchase plan(1)
|
(
|
)
|
$
|
|
||||
Remaining repurchase authorization March 31, 2021
|
|
ITEM 2: |
MANAGEMENT’S DISCUSSION AND ANALYSIS (“MD&A”) OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
• |
Gabelli Private Equity Partners, LLC (“GPEP”), formed in August 2017 with $150 million of authorized capital as a “fundless” sponsor.
|
• |
Gabelli Special Purpose Acquisition Vehicles ("SPAC"), which commenced in 2018 with the launch of the Gabelli Value for Italy S.p.a., a general sector SPAC (VALU) that was listed on the London Stock Exchange's Borsa Italiana AIM
segment. On September 22, 2020, Associated Capital completed the $175 million initial public offering of its special purpose acquisition corporation (“SPAC”), PMV Consumer Acquisition Corp. (NYSE:PMVC). PMV Consumer Acquisition Corp.
(“PMV”) was created to pursue an initial business combination following the consumer globally with companies having an enterprise valuation in the range of $200 million to $3.5 billion.
|
• |
Finally, Gabelli Principal Strategies Group, LLC (“GPS”) was created to pursue strategic operating initiatives broadly.
|
First Quarter
|
||||||||
2022
|
2021
|
|||||||
AUM - end of period (in millions)
|
$
|
1,839
|
$
|
1,495
|
||||
AUM - average (in millions)
|
1,801
|
1,431
|
||||||
Net income/(loss) per share-diluted
|
$
|
(0.73
|
)
|
$
|
0.83
|
|||
Book Value Per Share
|
$
|
41.72
|
$
|
41.22
|
Three Months Ended
March 31,
|
||||||||
2022
|
2021
|
|||||||
Revenues
|
||||||||
Investment advisory and incentive fees
|
$
|
2,486
|
$
|
2,225
|
||||
Other
|
96
|
100
|
||||||
Total revenues
|
2,582
|
2,325
|
||||||
Expenses
|
||||||||
Compensation
|
3,933
|
3,868
|
||||||
Management fee
|
-
|
2,663
|
||||||
Other operating expenses
|
1,955
|
2,159
|
||||||
Total expenses
|
5,888
|
8,690
|
||||||
Operating loss
|
(3,306
|
)
|
(6,365
|
)
|
||||
Other income (expense)
|
||||||||
Net gain/(loss) from investments
|
(15,610
|
)
|
31,321
|
|||||
Interest and dividend income
|
804
|
1,189
|
||||||
Interest expense
|
(33
|
)
|
(91
|
)
|
||||
Shareholder-designated contribution
|
(208
|
)
|
(1,737
|
)
|
||||
Total other income (expense), net
|
(15,047
|
)
|
30,682
|
|||||
Income/(loss) before income taxes
|
(18,353
|
)
|
24,317
|
|||||
Income tax expense/(benefit)
|
(4,848
|
)
|
5,590
|
|||||
Income/(loss) before noncontrolling interests
|
(13,505
|
)
|
18,727
|
|||||
Income/(loss) attributable to noncontrolling interests
|
2,681
|
172
|
||||||
Net income/(loss) attributable to Associated Capital Group, Inc.’s shareholders
|
$
|
(16,186
|
)
|
$
|
18,555
|
|||
Net income/(loss) per share attributable to Associated Capital Group, Inc.’s shareholders:
|
||||||||
Basic
|
$
|
(0.73
|
)
|
$
|
0.83
|
|||
Diluted
|
$
|
(0.73
|
)
|
$
|
0.83
|
|||
Weighted average shares outstanding:
|
||||||||
Basic
|
22,054
|
22,222
|
||||||
Diluted
|
22,054
|
22,222
|
% Change From
|
||||||||||||||||||||
March 31,
2022
|
December 31,
2021
|
March 31,
2021
|
December 31,
2021
|
March 31,
2021
|
||||||||||||||||
Merger Arbitrage
|
$
|
1,606
|
$
|
1,542
|
$
|
1,253
|
4.15
|
28.17
|
||||||||||||
Event-Driven Value
|
191
|
195
|
196
|
(2.05
|
)
|
(2.55
|
)
|
|||||||||||||
Other
|
42
|
44
|
46
|
(4.55
|
)
|
(8.70
|
)
|
|||||||||||||
Total AUM
|
$
|
1,839
|
$
|
1,781
|
$
|
1,495
|
3.26
|
23.01
|
December 31,
2021
|
Market
Appreciation/
(Depreciation)
|
Foreign Currency(1)
|
Net Inflows/
(Outflows)
|
March 31,
2022
|
||||||||||||||||
Merger Arbitrage
|
$
|
1,542
|
$
|
7
|
$
|
(20
|
)
|
$ |
77
|
$ |
1,606
|
|||||||||
Event-Driven Value
|
195
|
(4
|
)
|
-
|
-
|
191
|
||||||||||||||
Other
|
44
|
(1
|
)
|
-
|
(1
|
)
|
42
|
|||||||||||||
Total AUM
|
$
|
1,781
|
$
|
2
|
$
|
(20
|
)
|
$
|
76
|
$
|
1,839
|
Three Months Ended
March 31,
|
||||||||
2022
|
2021
|
|||||||
Cash flows provided by (used in) from continuing operations:
|
||||||||
Operating activities
|
$
|
28,558
|
$
|
243,568
|
||||
Investing activities
|
(1,773
|
)
|
710
|
|||||
Financing activities
|
(779
|
)
|
(4,062
|
)
|
||||
Net increase in cash, cash equivalents and restricted cash
|
26,006
|
240,216
|
||||||
Cash, cash equivalents and restricted cash at beginning of period
|
328,594
|
39,509
|
||||||
Cash, cash equivalents and restricted cash at end of period
|
$
|
354,600
|
$
|
279,725
|
ITEM 3: |
Quantitative and Qualitative Disclosures About Market Risk
|
ITEM 4. |
Controls and Procedures
|
• |
the adverse effect from a decline in the securities markets
|
• |
a decline in the performance of our products
|
• |
a general downturn in the economy
|
• |
changes in government policy or regulation
|
• |
changes in our ability to attract or retain key employees
|
• |
unforeseen costs and other effects related to legal
proceedings or investigations of governmental and self-regulatory organizations
|
PART II: |
Other Information
|
ITEM 1: |
Legal Proceedings
|
ITEM 1A: |
Risk Factors.
|
ITEM 2: |
Unregistered Sales of Equity Securities And Use Of Proceeds
|
Period
|
Total
Number
of Shares
Repurchased
|
Average
Price Paid
Per Share, net
of Commissions
|
Total
Number of Shares
Repurchased as Part of
Publicly Announced
Plans or Programs
|
Maximum
Number of Shares
That May Yet Be
Purchased Under the
Plans or Programs
|
||||||||||||
01/01/22 - 01/31/22
|
-
|
$
|
-
|
-
|
677,144
|
|||||||||||
02/01/22 - 02/28/22
|
7,136
|
38.76
|
7,136
|
670,008
|
||||||||||||
03/01/22 - 03/31/22
|
400
|
40.41
|
400
|
669,608
|
||||||||||||
Totals
|
7,536
|
$
|
38.84
|
7,536
|
ITEM 6: |
(a) Exhibits
|
Exhibit
Number
|
Description of Exhibit
|
|
Separation and Distribution Agreement, dated November 30, 2015, between GAMCO Investors, Inc., a Delaware corporation (“GAMCO”), and
Associated Capital Group, Inc., a Delaware corporation (the “Company”). (Incorporated by reference to Exhibit 2.1 to the Company’s Form 8-K dated November 30, 2015 filed with the Securities and Exchange Commission on December 4, 2015).
|
||
Amended and Restated Certificate of Incorporation of the Company. (Incorporated by reference to Exhibit 3.1 to the Company’s Form 8-K
dated November 19, 2015 filed with the Securities and Exchange Commission on November 25, 2015).
|
||
Amended and Restated Bylaws of the Company. (Incorporated by reference to Exhibit 3.2 to the Company’s Report on Form 8-K dated
November 19, 2015 filed with the Securities and Exchange Commission on November 25, 2015).
|
||
Form of Common Stock Certificate. (Incorporated by reference to Exhibit 4.1 to Amendment No. 4 to the Company’s Registration Statement
on Form 10 filed with the Securities and Exchange Commission on October 21, 2015).
|
||
Description of The Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934. (Incorporated by
reference to Exhibit 4.2 of the Company’s Report on Form 10-K filed with the Commission on March 16, 2020).
|
||
10.1
|
Service Mark and Name License Agreement, dated November 30, 2015, by and between the Company and GAMCO. (Incorporated by reference to
Exhibit 10.1 to the Company’s Form 8-K dated November 30, 2015 filed with the Commission on December 4, 2015).
|
|
Transitional Administrative and Management Services Agreement, dated November 30, 2015, by and between the Company and GAMCO.
(Incorporated by reference to Exhibit 10.2 to the Company’s Form 8-K dated November 30, 2015 filed with the Commission on December 4, 2015).
|
||
Employment Agreement between the Company and Mario J. Gabelli dated November 30, 2015 (Incorporated by reference to Exhibit 10.3 to
the Company’s Form 8-K dated November 30, 2015 filed with the Commission on December 4, 2015).
|
||
Promissory Note in aggregate principal amount of $250,000,000, dated November 30, 2015, issued by GAMCO in favor of the Company
(Incorporated by reference to Exhibit 10.4 to the Company’s Form 8-K dated November 30, 2015 filed with the Commission on December 4, 2015).
|
||
Tax Indemnity and Sharing Agreement, dated November 30, 2015, by and between the Company and GAMCO. (Incorporated by reference to
Exhibit 10.5 to the Company’s Form 8-K dated November 30, 2015 filed with the Commission on December 4, 2015).
|
||
2015 Stock Award Incentive Plan (Incorporated by reference to Exhibit 10.11 to Amendment No. 4 to the Company’s Registration Statement
on Form 10 filed with the Securities and Exchange Commission on October 21, 2015).
|
||
Form of Indemnification Agreement by and between the Company and the Indemnitee defined therein (Incorporated by reference to Exhibit
10.7 to Amendment No. 4 to the Company’s Registration Statement on Form 10 filed with the Securities and Exchange Commission on October 21, 2015).
|
||
Agreement and Plan of Merger, dated as of October 31, 2019, by and among Morgan Group Holding Co., G.R. acquisition, LLC, G.research,
LLC, Institutional Services Holdings, LLC and Associated Capital Group, Inc. (Incorporated by reference to Exhibit 2.1 to the Current Report on Form 8-K of Morgan Group Holding Co. filed with the Securities and Exchange Commission on
November 6, 2019).
|
||
Certification of CEO pursuant to Rule 13a-14(a).
|
Certification of CFO pursuant to Rule 13a-14(a).
|
||
Certification of CEO pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
||
Certification of CFO pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes- Oxley Act of 2002.
|
||
101.INS
|
Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)
|
|
101.SCH
|
Inline XBRL Taxonomy Extension Schema Document
|
|
101.CAL
|
Inline XBRL Taxonomy Extension Calculation Linkbase Document
|
|
101.DEF
|
Inline XBRL Taxonomy Extension Definition Linkbase Document
|
|
101.LAB
|
Inline XBRL Taxonomy Extension Label Linkbase Document
|
|
101.PRE
|
Inline XBRL Taxonomy Extension Presentation Linkbase Document
|
|
104
|
Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)
|
ASSOCIATED CAPITAL GROUP, INC.
|
||
(Registrant)
|
||
By:
|
/s/ Timothy H. Schott
|
|
Name:
|
Timothy H. Schott
|
|
Title:
|
Chief Financial Officer
|
|
Date: May 5, 2022
|